Côte d'Ivoire vs Panama: Share of pregnant women with HIV that receive antiretroviral therapy
Côte d'Ivoire
88.0%
in 2024
Panama
86.0%
in 2024
Côte d'Ivoire rank
31st
Panama rank
34th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Côte d'Ivoire
- Panama
How they compare
Côte d'Ivoire currently reports 88.0% against 86.0% in Panama, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Panama ahead.
Côte d'Ivoire ranks 31st and Panama ranks 34th of 84 countries.
Across the 3 decades both report, Côte d'Ivoire averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Côte d'Ivoire | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 41.4% | 28.4% | Panama |
| 2010s | 75.3% | 77.7% | 2.4% | Panama |
| 2020s | 90.6% | 85.0% | 5.6% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Côte d'Ivoire or Panama?
- Côte d'Ivoire, at 88.0% against 86.0% in Panama as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Côte d'Ivoire and Panama?
- 2.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Côte d'Ivoire and Panama rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Côte d'Ivoire ranks 31st and Panama ranks 34th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.